107 filings
Page 3 of 6
D/A
5i9byjhr
4 Jan 13
$4.8M in equity / options, sold $2.14M, 56 investors
12:00am
D/A
f95o6k19wom3
4 Jan 13
$4.8M in equity / options, sold $2.01M, 54 investors
12:00am
8-K
eogb0ikthmzszuu7p2
11 Dec 12
Unregistered Sales of Equity Securities
12:00am
8-K
gsp1bmquq c1i5ho0
11 Dec 12
Unregistered Sales of Equity Securities
12:00am
8-K
lpegvir4qdgx79
16 Oct 12
Arrogene presents breakthrough nanobioplatform at the 11th Annual BIO Investor Forum
12:00am
8-K
jdtw6szzf0
10 Sep 12
Amendments to Articles of Incorporation or Bylaws
12:00am
DEF 14C
3v8hnjuc
14 Aug 12
Information statement
12:00am
UPLOAD
8wwy4fnxean836toz
9 Aug 12
Letter from SEC
12:00am
8-K/A
as7n5sdsjb 3h5x
24 Jul 12
Entry into a Material Definitive Agreement
12:00am
CORRESP
mvm7w2
24 Jul 12
Correspondence with SEC
12:00am
D/A
3lyvv54tmvjgc5w6wnj
24 Jul 12
$4.8M in equity / options, sold $3.77M, 51 investors
12:00am
8-K
yfj8xmuzv
19 Jul 12
Unregistered Sales of Equity Securities
12:00am
UPLOAD
do05n2yfr0mzr0lgtrt
19 Jul 12
Letter from SEC
12:00am
CORRESP
drrf9y5 9n1v2fy
2 Jul 12
Correspondence with SEC
12:00am
8-K
hptio3pa79 qxu
21 Jun 12
Arrogene’s Innovative Multi-target Nano-platform for Cancer Therapeutics to Be Discussed at the 2012 Techconnect World Nanotechnology Conference
12:00am
NT 10-Q
4fpq6 u7kafqofr85
14 Jun 12
Notice of late quarterly filing
12:00am